Dirk Beher Ph.D.

Degree PhD
Title CEO
Organization Asceneuron SA
Address EPFL Innovation Park, Bâtiment B, 1015 Lausanne, Switzerland
Email dirk.beher@asceneuron.com


Dirk Beher is an experienced Founder, CEO and CSO in the European biopharmaceutical space with a global outreach. Since co-founding Asceneuron in 2012 he has served as the CEO/CSO and Member of the Board of Directors of the company. Dirk led the spinout of Asceneuron from a mid-size pharma and has successfully built a fully functional research and development company in the neurodegeneration space from the beginning. Under his leadership Asceneuron has raised to date over CHF 50M from leading venture capital firms and advanced CNS penetrant molecules for numerous protein misfolding diseases from discovery into mid-stage clinical development.

Besides, Dirk brings more than 30 years of research and drug development experience in the field of Alzheimer’s disease and neurodegeneration. Prior to Asceneuron, he spent 14 years in pharmaceutical drug discovery leading R&D teams around the globe at Merck Sharp & Dohme (Merck & Co.; UK), Amgen (USA) and Merck Serono (CH).

Educated at the Ruprecht-Karls-University Heidelberg, Germany Dirk holds a Ph.D. and a Diploma (M.S.) in Biology. He is an inventor of numerous patents and author of over 50 peer-reviewed publications and reviews.